| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |